FDA panel backs Vertex cystic-fibrosis drug Orkambi By: MarketWatch May 12, 2015 at 17:16 PM EDT Vertex Pharmaceuticals’ experimental cystic fibrosis drug Orkambi won the backing of an FDA panel, which voted 12 to 1 to recommend approval. Read More >> Related Stocks: Vertex Pharmaceuticals